A detrimental role for IgG and FcgammaR in Leishmania mexicana infection

Immunologic Research

Volumn 42, Issue 1-3, 2008, Pages 197-209

  Buxbaum, Laurence U ^a,b  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

FcgammaR; IL 10; IL 12; Immune complex; Immunoglobulin G; Leishmania; Macrophage; Protozoan parasite

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B LIPID COMPLEX; CD16 ANTIGEN; FC RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 10; INTERLEUKIN 12; MILTEFOSINE; NITRIC OXIDE; STAT4 PROTEIN; STIBOGLUCONATE SODIUM;

ADAPTIVE IMMUNITY; ANTIBODY RESPONSE; CYTOKINE PRODUCTION; DENDRITIC CELL; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE DELETION; HOST CELL; HUMAN; IMMUNE RESPONSE; LEISHMANIA MEXICANA; LEISHMANIASIS; MACROPHAGE; NEPHROTOXICITY; NONHUMAN; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SIGNAL TRANSDUCTION; SKIN LEISHMANIASIS; TH1 CELL; VISCERAL LEISHMANIASIS; ANIMAL; IMMUNOLOGY; PARASITOLOGY;

ANIMALS; HUMANS; IMMUNOGLOBULIN G; INTERLEUKIN-10; LEISHMANIA MEXICANA; LEISHMANIASIS, CUTANEOUS; MACROPHAGES; RECEPTORS, IGG; SIGNAL TRANSDUCTION; TH1 CELLS;

EID: 61849184975     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12026-008-8074-5     Document Type: Review

References (55)

1. WHO. World health report: reducing risks, promoting healthy life. 2002. p. 186.
2. WHO. WHO: leishmaniasis. 2005. http://www.who.int/leishmaniasis/en.
3. WHO. TDR disease portfolio. 2004. http://www.who.int/tdr/diseases/ default.htm.
4. S Hewitt H Reyburn R Ashford M Rowland 1998 Anthroponotic cutaneous leishmaniasis in Kabul, Afghanistan: vertical distribution of cases in apartment blocks Trans R Soc Trop Med Hyg 92 273 4 9861394 10.1016/S0035-9203(98)91007-0 1:STN:280:DyaK1M%2FnvVertQ%3D%3D (Pubitemid 28286921)
5. M Rowland A Munir N Durrani H Noyes H Reyburn 1999 An outbreak of cutaneous leishmaniasis in an Afghan refugee settlement in north-west Pakistan Trans R Soc Trop Med Hyg 93 133 6 10450434 10.1016/S0035-9203(99)90285-7 1:STN:280:DyaK1MznvV2hug%3D%3D (Pubitemid 29233847)
6. LJ Roberts E Handman SJ Foote 2000 Science, medicine, and the future: Leishmaniasis BMJ 321 801 4 11009521 10.1136/bmj.321.7264.801 1:STN:280:DC%2BD3M%2FhvFamsg%3D%3D
7. AJ Magill M Grogl RA Gasser Jr W Sun CN Oster 1993 Visceral infection caused by Leishmania tropica in veterans of Operation Desert Storm N Engl J Med 328 1383 7 8292114 10.1056/NEJM199305133281904 1:STN:280:ByyB3szntlQ%3D (Pubitemid 23131391)
8. AD Bryceson JD Chulay M Ho M Mugambii JB Were R Muigai, et al. 1985 Visceral leishmaniasis unresponsive to antimonial drugs. I. Clinical and immunological studies Trans R Soc Trop Med Hyg 79 700 4 3006294 10.1016/0035-9203(85)90197-X 1:STN:280:BimC2M3oslM%3D (Pubitemid 16249111)
9. TK Jha S Sundar CP Thakur P Bachmann J Karbwang C Fischer, et al. 1999 Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis N Engl J Med 341 1795 800 10588964 10.1056/NEJM199912093412403 1:CAS:528:DC%2BD3cXhsVektQ%3D%3D
10. P Escobar S Matu C Marques SL Croft 2002 Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B Acta Trop 81 151 7 11801222 10.1016/S0001-706X(01)00197-8 1:CAS:528:DC%2BD38XktFamtA%3D%3D (Pubitemid 34093805)
11. J Soto BA Arana J Toledo N Rizzo JC Vega A Diaz, et al. 2004 Miltefosine for new world cutaneous leishmaniasis Clin Infect Dis 38 1266 72 15127339 10.1086/383321 1:CAS:528:DC%2BD2cXksFers7Y%3D (Pubitemid 38608569)
12. Roberts LS, Janovy J Jr, editors. Kinetaplasta: trypanosomes and their kin. In: Gerald D Schmidt and Larry S Roberts' Foundations of parasitology. 6th ed. New York: McGraw Hill; 2000, p. 70-8.
13. Preston PM, DuMonde DC. Immunology of clinical and experimental leishmaniasis. In: Cohen S, Sadun EH, editors. Immunology of parasitic infections. Oxford: Blackwell Scientific Publications; 1976. p. 168-202.
14. RM Locksley P Scott 1991 Helper T-cell subsets in mouse leishmaniasis: induction, expansion and effector function Immunol Today 12 A58 61 1829891 10.1016/S0167-5699(05)80017-9 1:CAS:528:DyaK3MXmsFensLs%3D
15. GE Childs LK Lightner L McKinney MG Groves EE Price LD Hendricks 1984 Inbred mice as model hosts for cutaneous leishmaniasis. I. Resistance and susceptibility to infection with Leishmania braziliensis, L. mexicana, and L. aethiopica Ann Trop Med Parasitol 78 25 34 6721612 1:STN:280:BiuB3c3gt1w%3D
16. LU Buxbaum JE Uzonna MH Goldschmidt P Scott 2002 Control of New World cutaneous leishmaniasis is interleukin-12 independent but STAT4 dependent Eur J Immunol 32 3206 15 12555666 10.1002/1521-4141(200211)32:11<3206::AID- IMMU3206>3.0.CO;2-J 1:CAS:528:DC%2BD38XovF2qs70%3D (Pubitemid 35414878)
17. XQ Wei IG Charles A Smith J Ure GJ Feng FP Huang, et al. 1995 Altered immune responses in mice lacking inducible nitric oxide synthase Nature 375 408 11 7539113 10.1038/375408a0 1:CAS:528:DyaK2MXmtVehsbY%3D
18. A Diefenbach H Schindler N Donhauser E Lorenz T Laskay J MacMicking, et al. 1998 Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite Immunity 8 77 87 9462513 10.1016/S1074-7613(00)80460-4 1:CAS:528:DyaK1cXptVOksw%3D%3D (Pubitemid 28097825)
19. FP Heinzel RM Rerko F Ahmed E Pearlman 1995 Endogenous IL-12 is required for control of Th2 cytokine responses capable of exacerbating leishmaniasis in normally resistant mice J Immunol 155 730 9 7608551 1:CAS:528:DyaK2MXmvVagsLw%3D
20. DE Jones LU Buxbaum P Scott 2000 IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection J Immunol 165 364 72 10861073 1:CAS:528:DC%2BD3cXksVKltrs%3D
21. FP Heinzel DS Schoenhaut RM Rerko LE Rosser MK Gately 1993 Recombinant interleukin 12 cures mice infected with Leishmania major J Exp Med 177 1505 9 8097524 10.1084/jem.177.5.1505 1:CAS:528:DyaK3sXitFWisbs%3D
22. D Jones MM Ellosso L Showe D Williams G Trinchieri P Scott 1998 Differential regulation of the interleukin-12 receptor during the innate immune response to Leishmania major Infect Immun 66 3818 24 9673267 1:CAS:528:DyaK1cXltFCqs7s%3D
23. LU Buxbaum P Scott 2005 Interleukin 10- and Fcgamma receptor-deficient mice resolve Leishmania mexicana lesions Infect Immun 73 2101 8 15784551 10.1128/IAI.73.4.2101-2108.2005 1:CAS:528:DC%2BD2MXjtFygtbw%3D (Pubitemid 40470808)
24. KW Moore R de Waal Malefyt RL Coffman A O'Garra 2001 Interleukin-10 and the interleukin-10 receptor Annu Rev Immunol 19 683 765 11244051 10.1146/annurev.immunol.19.1.683 1:CAS:528:DC%2BD3MXivFKgu70%3D (Pubitemid 32368050)
25. DF Fiorentino MW Bond TR Mosmann 1989 Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones J Exp Med 170 2081 95 2531194 10.1084/jem.170.6.2081 1:CAS:528: DyaK3cXhtFKqtL0%3D (Pubitemid 20010086)
26. S Sad R Marcotte TR Mosmann 1995 Cytokine-induced differentiation of precursor mouse CD8+ T cells into cytotoxic CD8+ T cells secreting Th1 or Th2 cytokines Immunity 2 271 9 7697544 10.1016/1074-7613(95)90051-9 1:CAS:528:DyaK2MXkslSksr0%3D
27. KJ Maloy F Powrie 2001 Regulatory T cells in the control of immune pathology Nat Immunol 2 816 22 11526392 10.1038/ni0901-816 1:CAS:528: DC%2BD3MXmsFehs7c%3D (Pubitemid 34906442)
28. MG Roncarolo MK Levings C Traversari 2001 Differentiation of T regulatory cells by immature dendritic cells J Exp Med 193 F5 9 11208869 10.1084/jem.193.2.F5 1:CAS:528:DC%2BD3MXksl2guw%3D%3D
29. HH Uhlig J Coombes C Mottet A Izcue C Thompson A Fanger, et al. 2006 Characterization of Foxp3+CD4+CD25+ and IL-10-secreting CD4+CD25+ T cells during cure of colitis J Immunol 177 5852 60 17056509 1:CAS:528:DC%2BD28XhtFSns77E
30. CF Anderson M Oukka VJ Kuchroo D Sacks 2007 CD4+CD25-Foxp3- Th1 cells are the source of IL-10-mediated immune suppression in chronic cutaneous leishmaniasis J Exp Med 204 285 97 17283207 10.1084/jem.20061886 1:CAS:528:DC%2BD2sXitVekt7c%3D (Pubitemid 46294545)
31. K Taga H Mostowski G Tosato 1993 Human interleukin-10 can directly inhibit T-cell growth Blood 81 2964 71 8499633 1:CAS:528:DyaK3sXkvFegtL4%3D
32. EN Villegas U Wille L Craig PS Linsley DM Rennick R Peach, et al. 2000 Blockade of costimulation prevents infection-induced immunopathology in interleukin-10-deficient mice Infect Immun 68 2837 44 10768980 10.1128/IAI.68.5.2837-2844.2000 1:CAS:528:DC%2BD3cXivVamtbk%3D (Pubitemid 30253863)
33. ML Murphy U Wille EN Villegas CA Hunter JP Farrell 2001 IL-10 mediates susceptibility to Leishmania donovani infection Eur J Immunol 31 2848 56 11592059 10.1002/1521-4141(2001010)31:10<2848::AID-IMMU2848>3.0.CO;2-T 1:CAS:528:DC%2BD3MXnvFSgt78%3D (Pubitemid 32994535)
34. R Kuhn J Lohler D Rennick K Rajewsky W Muller 1993 Interleukin-10- deficient mice develop chronic enterocolitis Cell 75 263 74 8402911 10.1016/0092-8674(93)80068-P 1:STN:280:ByuD3cnlsFw%3D (Pubitemid 23320290)
35. H Louzir PC Melby A Ben Salah H Marrakchi K Aoun R Ben Ismail, et al. 1998 Immunologic determinants of disease evolution in localized cutaneous leishmaniasis due to Leishmania major J Infect Dis 177 1687 95 9607850 10.1086/515297 1:STN:280:DyaK1c3mvVyltA%3D%3D
36. CL Karp SH el-Safi TA Wynn MM Satti AM Kordofani FA Hashim, et al. 1993 In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma J Clin Invest 91 1644 8 8097208 10.1172/JCI116372 1:CAS:528:DyaK3sXisFeit7Y%3D
37. HW Ghalib MR Piuvezam YA Skeiky M Siddig FA Hashim AM el-Hassan, et al. 1993 Interleukin 10 production correlates with pathology in human Leishmania donovani infections J Clin Invest 92 324 9 8326000 10.1172/JCI116570 1:CAS:528:DyaK3sXlsFyis7w%3D
38. MM Kane DM Mosser 2001 The role of IL-10 in promoting disease progression in leishmaniasis J Immunol 166 1141 7 11145695 1:CAS:528:DC%2BD3MXlvVWnsg%3D%3D
39. CB Stober UG Lange MT Roberts A Alcami JM Blackwell 2005 IL-10 from regulatory T cells determines vaccine efficacy in murine Leishmania major Infection J Immunol 175 2517 24 16081824 1:CAS:528:DC%2BD2MXntVSqs74%3D
40. UM Padigel J Alexander JP Farrell 2003 The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis J Immunol 171 3705 10 14500669 1:CAS:528: DC%2BD3sXnvFSrtbk%3D
41. Y Belkaid CA Piccirillo S Mendez EM Shevach DL Sacks 2002 CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity Nature 420 502 7 12466842 10.1038/nature01152 1:CAS:528:DC%2BD38Xpt1Whs7w%3D (Pubitemid 35477041)
42. BN Thomas LU Buxbaum 2008 FcgammaRIII mediates immunoglobulin G-induced interleukin-10 and is required for chronic Leishmania mexicana lesions Infect Immun 76 623 31 18070890 10.1128/IAI.00316-07 1:CAS:528:DC%2BD1cXhsFOqsbg%3D (Pubitemid 351251732)
43. F Nimmerjahn P Bruhns K Horiuchi JV Ravetch 2005 FcgammaRIV: a novel FcR with distinct IgG subclass specificity Immunity 23 41 51 16039578 10.1016/j.immuni.2005.05.010 1:CAS:528:DC%2BD2MXnsVeltrk%3D (Pubitemid 41019656)
44. JV Ravetch S Bolland 2001 IgG Fc receptors Annu Rev Immunol 19 275 90 11244038 10.1146/annurev.immunol.19.1.275 1:CAS:528:DC%2BD3MXivFKgur4%3D (Pubitemid 32368037)
45. JS Gerber DM Mosser 2001 Stimulatory and inhibitory signals originating from the macrophage Fcgamma receptors Microbes Infect 3 131 9 11251299 10.1016/S1286-4579(00)01360-5 1:CAS:528:DC%2BD3MXit1CitLo%3D (Pubitemid 32209330)
46. CM Snapper WE Paul 1987 Interferon-gamma and B cell stimulatory factor-1 reciprocally regulate Ig isotype production Science 236 944 7 3107127 10.1126/science.3107127 1:CAS:528:DyaL2sXktlOktL0%3D
47. MT Berton JW Uhr ES Vitetta 1989 Synthesis of germ-line gamma 1 immunoglobulin heavy-chain transcripts in resting B cells: induction by interleukin 4 and inhibition by interferon gamma Proc Natl Acad Sci USA 86 2829 33 2495537 10.1073/pnas.86.8.2829 1:CAS:528:DyaL1MXitFSmt7c%3D (Pubitemid 19112633)
48. WL Hazenbos JE Gessner FM Hofhuis H Kuipers D Meyer IA Heijnen, et al. 1996 Impaired IgG-dependent anaphylaxis and Arthus reaction in Fc gamma RIII (CD16) deficient mice Immunity 5 181 8 8769481 10.1016/S1074-7613(00)80494-X 1:CAS:528:DyaK28XltlKjsbk%3D (Pubitemid 26301094)
49. WL Hazenbos IA Heijnen D Meyer FM Hofhuis CR Renardel de Lavalette RE Schmidt, et al. 1998 Murine IgG1 complexes trigger immune effector functions predominantly via Fc gamma RIII (CD16) J Immunol 161 3026 32 9743367 1:CAS:528:DyaK1cXmtVGnu7k%3D
50. D Meyer C Schiller J Westermann S Izui WL Hazenbos JS Verbeek, et al. 1998 FcgammaRIII (CD16)-deficient mice show IgG isotype-dependent protection to experimental autoimmune hemolytic anemia Blood 92 3997 4002 9834201 1:CAS:528:DyaK1cXnslylsr0%3D
51. L Fossati-Jimack A Ioan-Facsinay L Reininger Y Chicheportiche N Watanabe T Saito, et al. 2000 Markedly different pathogenicity of four immunoglobulin G isotype-switch variants of an antierythrocyte autoantibody is based on their capacity to interact in vivo with the low-affinity Fcgamma receptor III J Exp Med 191 1293 302 10770797 10.1084/jem.191.8.1293 1:CAS:528:DC%2BD3cXislSitLk%3D (Pubitemid 30227118)
52. C Taube A Dakhama YH Rha K Takeda A Joetham JW Park, et al. 2003 Transient neutrophil infiltration after allergen challenge is dependent on specific antibodies and Fc gamma III receptors J Immunol 170 4301 9 12682266 1:CAS:528:DC%2BD3sXislersL0%3D
53. MD Sadick HV Raff 1985 Differences in expression and exposure of promastigote and amastigote membrane molecules in Leishmania tropica Infect Immun 47 395 400 3881347 1:CAS:528:DyaL2MXht1yltL8%3D
54. E Medina-Acosta RE Karess H Schwartz DG Russell 1989 The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage Mol Biochem Parasitol 37 263 73 2691889 10.1016/0166-6851(89)90158-8 1:CAS:528:DyaK3cXntlCkuw%3D%3D
55. G Winter M Fuchs MJ McConville YD Stierhof P Overath 1994 Surface antigens of Leishmania mexicana amastigotes: characterization of glycoinositol phospholipids and a macrophage-derived glycosphingolipid J Cell Sci 107 Pt 9 2471 82 7844164 1:CAS:528:DyaK2MXpsVClug%3D%3D